Pharmaceuticals

Pharmaceutical Business Confidence Report Q4 2014

  • KAB153599
  • 73 Pages
  • November 2014
  • Pharmaceuticals
Summary
Pharmaceutical Business Confidence Report Q4 2014 is a new report by Kable that globally analyzes industry opinions on the latest economic and customer issues, and their impact on investment decisions and growth prospects within the pharmaceutical industry over October-December 2014. This report also examines executive opinions with regards to the current and future state of the economy and its effect on the industry. It analyzes the likely effect of supplier price changes, sales performance, and staff headcount within the industry. Furthermore, this report provides an overview of the key priorities, threats, and opportunities for the global pharmaceutical industry. In addition, the report includes the forecasts of the projected investments on pharmaceutical equipment, procurement budget allocations and the leading suppliers of pharmaceutical equipment in the pharmaceutical industry.

Key Findings
- Overall, 46% of pharmaceutical industry respondents state that they are operating in a stable economic environment, while 42% state that their current economic conditions are favorable
- The majority of global pharmaceutical industry respondents anticipate positive growth for both their companies and the industry over October-December 2014
- Industry respondents from Asia-Pacific expect the highest growth in staff headcount and sales volume in October-December 2014
- Improving operational efficiency and protecting and growing market share are the most popular priorities by pharmaceutical industry executives operating across all regions
- Highest percentage, 79%, of the survey respondents operating in Europe gives high preference for outright purchase in Q4 2014, while 21% of the respondents show less preference
- Respondents intend to allocate the biggest part of their procurement budget towards meeting operating expenses in 2015
- Survey results indicated that 35% of the survey respondents invest on the laboratory instrument every year.

Synopsis
This report is the result of an extensive survey drawn from Kable's exclusive panel of leading global pharmaceutical industry executives. The report analyzes current global economic conditions and their impact on the pharmaceutical industry, and forecasts the company and industry growth prospects over October-December 2014. It provides information about the impact of customer confidence, supplier prices, and staff headcount likely to affect investment decisions October-December 2014. Additionally, the report includes the trends in the pharmaceutical equipment market, analysis of the procurement budget allocations and leading suppliers of pharmaceutical equipment.

In particular, it provides an in-depth analysis of the following:

- Industry executives' opinions about the current state of the global economy, examining the prevailing economic conditions and executives' opinions with regards to the global economy and the state of economic conditions in various regions
- The growth prospects of companies and the industry as a whole, providing industry executives' expectations on the growth prospects of their company and the Industry over October-December 2014
- Change in customer confidence, analyzing pharmaceutical industry executives' opinions on changes in customer confidence globally, over October-December 2014
- Impact of supplier prices, determining the expected change in supplier prices across various categories and their impact on business confidence, and examines the key factors influencing the change
- Change in staff headcount and sales performance, tracking the expected changes in staff headcount and sales among industry executives operating in various regions, over October-December 2014
- Investment activities, ascertaining the various investment activities on which industry executives intend to focus on over October-December 2014
- Business concerns, examining industry executives' attitudes towards various business concerns and provides regional analysis
- Key priorities, identifying the immediate business priorities of pharmaceutical industry executives over October-December 2014
- Purchase preferences: analyzing the purchasing behavior towards pharmaceutical equipment and investment allocations in the pharmaceutical equipment categories
- Budget allocation: examining total procurement budget split between capital expenditure and operating expenditure, and tracking the changes in the budget for 2014 and expectations for 2015.

ReasonsToBuy
- The report projects the current and future operating conditions of the pharmaceutical industry, and allows readers to make effective business decisions
- The report helps readers make strategic decisions by understanding the present and future economic and customer issues, including key growth regions
- Pharmaceutical industry suppliers will be provided with a clear uncovering of the key challenges and opportunities, and identify the key priorities likely to affect the industry's growth prospects
- The report forecasts the change in supplier prices of various products, which are likely to influence the industry's growth prospects over October-December 2014
- The report helps executives to recognize the change in customer confidence levels in the global pharmaceutical industry over October-December 2014
- The report enables the executives to take key decisions on purchase preferences and investments in pharmaceutical equipment.
Please Select Format

Enquiry About Report

Need More Information

Contact us
+ 1-800-910-6452
+1-971-202-1575
+91 20 66346066
--- or ---
help@bigmarketresearch.com

 

UPCOMING MARKET RESEARCH REPORTS

Global General Medicine Education Publishing Market (Type, Geography) Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Opportunities, Segmentation, Forecast (2013-2020)

General medicine is a branch of medicine that deals with diagnosis and treatment of diseases associated with internal organs. It is also called as Internal Medicine. General medicine education market has shown substantial growth due to the adoption of internal medicine as a career option by medical students.

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Cancer Vaccine Market Global Scenario, Market Size, Outlook, Trend and Forecast, 2015- 2024

Cancer vaccines are biological response modifiers. These vaccines work by stimulating or restoring the immune system’s ability to fight against infections and diseases. It is used either as stand-alone therapies ...

March 2017  |   Price:$ 7695    | Pre Book Price:$ 7695

Read More >>

Radiopharmaceuticals Market Global Scenario, Market Size, Outlook, Trend and Forecast, 2015- 2024

Radiopharmaceutical is a radioactive pharmaceutical agent which is used diagnostic or therapeutic procedures. A radiopharmaceutical is made up of two components that are drug component and radioactive component. This radioactive ...

March 2017  |   Price:$ 7695    | Pre Book Price:$ 7695

Read More >>

Pharmaceutical Excipients Market Global Scenario, Market Size, Outlook, Trend and Forecast, 2015- 2024

Pharmaceutical excipients are substances other than the pharmacologically active drug or prodrug which are included in the manufacturing process or are contained in a finished pharmaceutical product dosage form. The ...

March 2017  |   Price:$ 7695    | Pre Book Price:$ 7695

Read More >>

Over the Counter (OTC) & Diet Supplementary Market Global Scenario, Market Size, Outlook, Trend and Forecast, 2015- 2024

Over the counter (OTC) drugs are those drugs which can be picked by consumer without the prescription of doctors intended to use for diagnosis, cure, mitigation, treatment or prevention of ...

March 2017  |   Price:$ 7695    | Pre Book Price:$ 7695

Read More >>

World Active Pharmaceutical Ingredient (API) Market - Opportunities and Forecasts, 2014 - 2020

Increase in Abbreviated New Drug Applications (ANDA) over the past years has fostered the demand for API market. Furthermore, Indian companies making increased entries related to Drug Master File (DMF) ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

2017 © Copyright Big Market Research

View Pricing >>